MepolizumabQualityChecker
Mepolizumab
Mepolizumab Quality Checker — Biologic Drug (Anti-IL-5 mAb) (Ph. Eur., USP) ℹ️ The utility checks aggregates, potency, glycosylation, HCP, sterility, endotoxins, particles. ℹ️ Does not use machine learning — rule-based logic only. ⚠️ CRITICAL! Aggregates ≤1.0%. Sterility mandatory. Endotoxins ≤1.0 EU/mg! Usage: MepolizumabQualityChecker.exe → demo mode MepolizumabQualityChecker.exe input.csv output.json → evaluate data Input format: BatchNumber,Protein_Concentration_mgPerMl,Potency_Percent,pH_Value,Osmolality_mOsm_kg,Aggregate_Percent_SEC,Fragment_Percent_SEC,Acidic_Variants_Percent_IEC,Basic_Variants_Percent_IEC,Glycosylation_G0F_Percent,Host_Cell_Protein_ppm,Residual_DNA_ngPerMl,Protein_A_Leaching_ngPerMl,SterilityTest,Endotoxin_EU_per_mg,Subvisible_Particles_2_10_um,Subvisible_Particles_10_25_um,Subvisible_Particles_gt_25_um,Appearance_Score Example: MEP-BIO-2026-001,100.2,97.5,6.0,290,0.35,0.25,17.0,6.0,28.0,18,1.8,3.5,0,0.12,1000,100,5,0 — WHY IS THIS NEEDED? Mepolizumab — fully human IgG1κ monoclonal antibody against IL-5 for severe eosinophilic asthma treatment: • Administered subcutaneously, so sterility and endotoxin requirements are maximum. • Aggregates (HMW): Critical parameter. Aggregates can cause immune response and reduced efficacy. Limit is strict (≤1.0%). • Potency: Measured by ability to bind IL-5. Deviation leads to treatment inefficacy. • Glycosylation: Sugar profile affects antibody clearance and pharmacokinetics. Control within specified range is mandatory. • Process Impurities: HCP (CHO cell proteins), DNA, and Protein A must be removed to trace levels. • Particles: Subvisible particles are dangerous for injection, so control is strict (USP <788>). ⚠️ CRITICAL: • Protein Concentration: 98.0–102.0 mg/mL (for 100 mg/mL form) • Potency: 80–120% of standard • Aggregates: ≤ 1.0% • Glycosylation (G0F): 10–40% • HCP: ≤ 50 ppm • DNA: ≤ 10 ng/mL • Sterility: No growth • Endotoxins: ≤ 1.0 EU/mg • Particles >25 µm: ≤ 60 counts/mL • Appearance: Clear, colorless ⚠️ Note: Utility accounts for therapeutic antibody specifics with high injection reaction risk. Aggregate and endotoxin control is more important than for many other drugs as they directly impact infusion/injection safety. Sterility is absolute requirement. Deamidation (acidic peaks) controlled as stability marker during storage.
input.csv
BatchNumber,Protein_Concentration_mgPerMl,Potency_Percent,pH_Value,Osmolality_mOsm_kg,Aggregate_Percent_SEC,Fragment_Percent_SEC,Acidic_Variants_Percent_IEC,Basic_Variants_Percent_IEC,Glycosylation_G0F_Percent,Host_Cell_Protein_ppm,Residual_DNA_ngPerMl,Protein_A_Leaching_ngPerMl,SterilityTest,Endotoxin_EU_per_mg,Subvisible_Particles_2_10_um,Subvisible_Particles_10_25_um,Subvisible_Particles_gt_25_um,Appearance_Score MEP-BIO-2026-001,100.2,97.5,6.0,290,0.35,0.25,17.0,6.0,28.0,18,1.8,3.5,0,0.12,1000,100,5,0
URS & FS — user requirements and functional specification
This document defines user requirements and functional specification for the quality-control utility. It supports deployment discussion, IQ/OQ preparation and QC workflow integration.
1. Scope
The Mepolizumab Quality Checker utility is used for Mepolizumab. The actual input.csv is the source of truth for the input structure; control criteria are defined by the executable and the domain description.
The utility does not use machine learning; decisions are produced by deterministic rules.
Categories: Global API expansion
Tags: antivirals, API, biologics, endotoxins, essential medicines, global market, impurities, infusions, injectables, oncology, sterility
2. Execution modes
MepolizumabQualityChecker.exe → demo mode MepolizumabQualityChecker.exe input.csv output.json → evaluate data
3. Key controlled areas
- assay / content
- microbiology and pathogens
- pH and physicochemical parameters
4. Domain limits and critical parameters
- ⚠️ CRITICAL! Aggregates ≤1.0%. Sterility mandatory. Endotoxins ≤1.0 EU/mg!
- Aggregates (HMW): Critical parameter. Aggregates can cause immune response and reduced efficacy. Limit is strict (≤1.0%).
- Particles: Subvisible particles are dangerous for injection, so control is strict (USP <788>).
- ⚠️ CRITICAL:
- Protein Concentration: 98.0–102.0 mg/mL (for 100 mg/mL form)
- Potency: 80–120% of standard
- Aggregates: ≤ 1.0%
- Glycosylation (G0F): 10–40%
- HCP: ≤ 50 ppm
- DNA: ≤ 10 ng/mL
- Sterility: No growth
- Endotoxins: ≤ 1.0 EU/mg
- Particles >25 µm: ≤ 60 counts/mL
- Appearance: Clear, colorless
- ⚠️ Note: Utility accounts for therapeutic antibody specifics with high injection reaction risk. Aggregate and endotoxin control is more important than for many other drugs as they directly impact infusion/injection safety. Sterility is absolute requirement. Deamidation (acidic peaks) controlled as stability marker during storage.
5. URS — user requirements
| ID | Requirement | Criticality | Acceptance criterion |
|---|---|---|---|
| URS-001 | The system shall accept an input.csv file for Mepolizumab with the exact columns listed in the “Input data contract” section. | High | A file with the correct header is processed without manual editing; missing mandatory columns produce FAIL/import error. |
| URS-002 | The system shall support execution without arguments in demo mode and execution with input.csv output.json for user data. | Medium | Both execution scenarios produce a predictable result or clear diagnostic error. |
| URS-003 | The system shall perform rule-based controls for: assay / content, microbiology and pathogens, pH and physicochemical parameters. | High | Each controlled parameter receives a status and message; the result does not depend on hidden Excel formulas or ML. |
| URS-004 | The system shall preserve traceability between batch/lot, source values, applied rules and final verdict. | High | Output includes batch identifier, source values, parameter statuses and critical findings. |
| URS-005 | The system shall generate machine-readable output.json for LIMS/ELN/MES, batch record and QA/QC review. | High | JSON contains overall status, check array, warnings, failures and source-file reference. |
| URS-006 | The system shall support use in the client validation package: URS/FS, IQ/OQ preparation, installation and operational scenario checks. | High | The document, test scenarios and reproducible CSV/JSON flow are suitable for audit and internal approval. |
| URS-007 | The system shall clearly separate technical data errors from specification nonconformities. | Medium | Schema/type errors are not mixed with pharmacopoeial deviations and are reported separately. |
6. input.csv data contract
The source of truth for the input schema is the actual input.csv header. Column names are technical identifiers and are not translated.
| # | Column | Type | Unit | Description | Sample | Control rule |
|---|---|---|---|---|---|---|
| 1 | BatchNumber | identifier | as specified | Batch Number | MEP-BIO-2026-001 | mandatory field; used for batch/lot traceability |
| 2 | Protein_Concentration_mgPerMl | decimal | mg/ml | Protein Concentration mg per Ml | 100.2 | numeric value; compared with assay/purity limit from specification or method |
| 3 | Potency_Percent | decimal | % | Potency % | 97.5 | mandatory numeric value; rule comparison is performed by the utility |
| 4 | pH_Value | decimal | pH | p H Value | 6.0 | mandatory numeric value; rule comparison is performed by the utility |
| 5 | Osmolality_mOsm_kg | decimal | mOsm/kg | Osmolality m Osm kg | 290 | mandatory numeric value; rule comparison is performed by the utility |
| 6 | Aggregate_Percent_SEC | decimal | % | Aggregate % SEC | 0.35 | mandatory numeric value; rule comparison is performed by the utility |
| 7 | Fragment_Percent_SEC | decimal | % | Fragment % SEC | 0.25 | mandatory numeric value; rule comparison is performed by the utility |
| 8 | Acidic_Variants_Percent_IEC | decimal | % | Acidic Variants % IEC | 17.0 | mandatory numeric value; rule comparison is performed by the utility |
| 9 | Basic_Variants_Percent_IEC | decimal | % | Basic Variants % IEC | 6.0 | mandatory numeric value; rule comparison is performed by the utility |
| 10 | Glycosylation_G0F_Percent | decimal | % | Glycosylation G0 F % | 28.0 | mandatory numeric value; rule comparison is performed by the utility |
| 11 | Host_Cell_Protein_ppm | decimal | ppm | Host Cell Protein ppm | 18 | mandatory numeric value; rule comparison is performed by the utility |
| 12 | Residual_DNA_ngPerMl | decimal | as specified | Residual DNA ng per Ml | 1.8 | mandatory numeric value; rule comparison is performed by the utility |
| 13 | Protein_A_Leaching_ngPerMl | decimal | as specified | Protein A Leaching ng per Ml | 3.5 | mandatory numeric value; rule comparison is performed by the utility |
| 14 | SterilityTest | boolean / flag | 0/1 | Sterility Test | 0 | valid flag required; prohibited organisms and growth are normally expected as 0 / absent |
| 15 | Endotoxin_EU_per_mg | decimal | EU/ml | Endotoxin EU per mg | 0.12 | numeric value; critical safety attribute compared with endotoxin limit |
| 16 | Subvisible_Particles_2_10_um | decimal | µm | Subvisible Particles 2 10 um | 1000 | mandatory numeric value; rule comparison is performed by the utility |
| 17 | Subvisible_Particles_10_25_um | decimal | µm | Subvisible Particles 10 25 um | 100 | mandatory numeric value; rule comparison is performed by the utility |
| 18 | Subvisible_Particles_gt_25_um | decimal | µm | Subvisible Particles gt 25 um | 5 | mandatory numeric value; rule comparison is performed by the utility |
| 19 | Appearance_Score | decimal | as specified | Appearance Score | 0 | mandatory numeric value; rule comparison is performed by the utility |
CSV example
BatchNumber,Protein_Concentration_mgPerMl,Potency_Percent,pH_Value,Osmolality_mOsm_kg,Aggregate_Percent_SEC,Fragment_Percent_SEC,Acidic_Variants_Percent_IEC,Basic_Variants_Percent_IEC,Glycosylation_G0F_Percent,Host_Cell_Protein_ppm,Residual_DNA_ngPerMl,Protein_A_Leaching_ngPerMl,SterilityTest,Endotoxin_EU_per_mg,Subvisible_Particles_2_10_um,Subvisible_Particles_10_25_um,Subvisible_Particles_gt_25_um,Appearance_Score MEP-BIO-2026-001,100.2,97.5,6.0,290,0.35,0.25,17.0,6.0,28.0,18,1.8,3.5,0,0.12,1000,100,5,0
7. FS — functional specification
| ID | Function | Implementation description |
|---|---|---|
| FS-001 | CLI entry point | The executable MepolizumabQualityChecker.exe supports demo mode and input.csv output.json processing mode. |
| FS-002 | CSV parser | The import module reads CSV, validates header, column presence/order, value count and encoding. Decimal values are expected with a dot separator. |
| FS-003 | Field conversion | Each column is converted to the expected type: identifier, text, decimal number, date/time or boolean flag. |
| FS-004 | Domain rule engine | For Mepolizumab, explicit rules are applied: range, minimum, maximum, absence of prohibited flag, data completeness or calculation-based check. |
| FS-005 | Criticality handling | Critical violations produce FAIL; non-critical deviations and incomplete data produce WARNING; full conformance produces PASS. |
| FS-006 | JSON writer | output.json stores overall status, per-parameter results, source values, warnings, failures and diagnostic messages. |
| FS-007 | Integration contract | The CSV → JSON format is stable for invocation from LIMS/ELN/MES, scheduled task or wrapper service. |
| FS-008 | Error handling | Schema error, missing file, non-numeric value or JSON write failure returns diagnosable error without silent PASS. |
8. output.json contract
The output file must be suitable for automated processing, audit review and correlation with the source input.csv row.
{
"utility": "MepolizumabQualityChecker",
"api": "Mepolizumab",
"batchNumber": "MEP-BIO-2026-001",
"overallStatus": "PASS|WARNING|FAIL",
"checkedAtUtc": "2026-05-18T00:00:00Z",
"checks": [
{
"parameter": "BatchNumber",
"value": "MEP-BIO-2026-001",
"unit": "as specified",
"status": "PASS|WARNING|FAIL",
"message": "Rule-based check result"
},
{
"parameter": "Protein_Concentration_mgPerMl",
"value": "100.2",
"unit": "mg/ml",
"status": "PASS|WARNING|FAIL",
"message": "Rule-based check result"
},
{
"parameter": "Potency_Percent",
"value": "97.5",
"unit": "%",
"status": "PASS|WARNING|FAIL",
"message": "Rule-based check result"
},
{
"parameter": "pH_Value",
"value": "6.0",
"unit": "pH",
"status": "PASS|WARNING|FAIL",
"message": "Rule-based check result"
},
{
"parameter": "Osmolality_mOsm_kg",
"value": "290",
"unit": "mOsm/kg",
"status": "PASS|WARNING|FAIL",
"message": "Rule-based check result"
},
{
"parameter": "Aggregate_Percent_SEC",
"value": "0.35",
"unit": "%",
"status": "PASS|WARNING|FAIL",
"message": "Rule-based check result"
},
{
"parameter": "Fragment_Percent_SEC",
"value": "0.25",
"unit": "%",
"status": "PASS|WARNING|FAIL",
"message": "Rule-based check result"
},
{
"parameter": "Acidic_Variants_Percent_IEC",
"value": "17.0",
"unit": "%",
"status": "PASS|WARNING|FAIL",
"message": "Rule-based check result"
}
],
"criticalFindings": [],
"sourceFile": "input.csv"
}9. OQ/PQ test scenarios
| ID | Scenario | Expected result |
|---|---|---|
| TC-001 | Valid CSV with expected header and sample row | All rows are processed; output contains PASS/WARNING/FAIL and parameter-level detail. |
| TC-002 | A mandatory input.csv column is missing | Import is rejected or the row receives FAIL with schema reference. |
| TC-003 | A numeric field contains text or a blank value | Type conversion error is recorded; the result is not hidden as PASS. |
| TC-004 | A parameter is outside specification or critical limit | Critical parameters produce FAIL; non-critical deviations produce WARNING according to the rule. |
| TC-005 | Positive pathogen/microbiological flag or microbiological limit excursion | Critical FAIL is produced with the offending parameter. |
10. QA/QC, CSV and change control
- Before production use, the client records executable version, checksum, specification/monograph version, test CSV, expected JSON and IQ/OQ results.
- Column names must not be changed without updating the validator and test scenarios.
- The source CSV, output.json and utility version should be stored together as an evidence package.
- Any change in control rules must go through change control and repeated OQ scenario verification.
Included in packages
Australia: national essential medicines QC package
QC utility package aligned with the country essential/reimbursed medicines list analogue and cross-checked against WHO EML. Only utilities already present in the portal are included; the package is a validation/discussion starting map, not an official registry copy.
OpenBiopharmaceuticals Core QC Suite
Focused QC utility package for biologic products: HCP, mAbs, biosimilars, proteins/peptides, sterility, endotoxins and key release checks.
OpenBiopharmaceuticals Extended QC Suite
Extended QC utility coverage for mAbs, biosimilars, proteins, insulins, vaccines, mRNA/LNP, HCP, sterile release, microbiology, water, cleanroom and stability workflows.
OpenCanada: national essential medicines QC package
QC utility package aligned with the country essential/reimbursed medicines list analogue and cross-checked against WHO EML. Only utilities already present in the portal are included; the package is a validation/discussion starting map, not an official registry copy.
OpenFrance: national essential medicines QC package
QC utility package aligned with the country essential/reimbursed medicines list analogue and cross-checked against WHO EML. Only utilities already present in the portal are included; the package is a validation/discussion starting map, not an official registry copy.
OpenGermany: national essential medicines QC package
QC utility package aligned with the country essential/reimbursed medicines list analogue and cross-checked against WHO EML. Only utilities already present in the portal are included; the package is a validation/discussion starting map, not an official registry copy.
OpenImmunology QC Suite
QC utility package for immunology: monoclonal antibodies, biosimilars, immunomodulators, immunosuppressants, ELISA/SPR, HCP, protein characterization, sterility and pyrogen/release checks.
OpenItaly: national essential medicines QC package
QC utility package aligned with the country essential/reimbursed medicines list analogue and cross-checked against WHO EML. Only utilities already present in the portal are included; the package is a validation/discussion starting map, not an official registry copy.
OpenJapan: national essential medicines QC package
QC utility package aligned with the country essential/reimbursed medicines list analogue and cross-checked against WHO EML. Only utilities already present in the portal are included; the package is a validation/discussion starting map, not an official registry copy.
OpenRussia: national essential medicines QC package
QC utility package aligned with the country essential/reimbursed medicines list analogue and cross-checked against WHO EML. Only utilities already present in the portal are included; the package is a validation/discussion starting map, not an official registry copy.
OpenSaudi Arabia: national essential medicines QC package
QC utility package aligned with the country essential/reimbursed medicines list analogue and cross-checked against WHO EML. Only utilities already present in the portal are included; the package is a validation/discussion starting map, not an official registry copy.
OpenSouth Korea: national essential medicines QC package
QC utility package aligned with the country essential/reimbursed medicines list analogue and cross-checked against WHO EML. Only utilities already present in the portal are included; the package is a validation/discussion starting map, not an official registry copy.
OpenUnited Kingdom: national essential medicines QC package
QC utility package aligned with the country essential/reimbursed medicines list analogue and cross-checked against WHO EML. Only utilities already present in the portal are included; the package is a validation/discussion starting map, not an official registry copy.
OpenUnited States: national essential medicines QC package
QC utility package aligned with the country essential/reimbursed medicines list analogue and cross-checked against WHO EML. Only utilities already present in the portal are included; the package is a validation/discussion starting map, not an official registry copy.
OpenWorld API Extension QC Suite
Extended package for 130 additional high-demand APIs and biological products prepared as a market-coverage backlog.
Open